Cannabis Use and Arthroplasty Outcomes: Key Findings from 2024 Meta-Analysis
Introduction Yang et al. (Front Public Health, May 2024) conducted a systematic review and meta-analysis to examine the association between […]
Provider Research
Cannabis Post-Arthroplasty: Increased Risks Highlighted in 2023 Meta-Analysis
Introduction The meta-analysis by Turan et al. (J Arthroplasty, Feb 2024, published July 2023) examines the relationship between cannabis use
Exploring Cannabis Use in ADHD Management: Findings from a 2023 Scoping Review
Introduction Francisco et al. published a scoping review in The Journal of Psychiatric Research on November 25, 2022, analyzing existing
Cannabinoid Pharmacology and Mechanisms of Action: A Comprehensive 2020 Analysis
Introduction The 2020 study by Schurman et al., published in Handbook of Experimental Pharmacology, provides an in-depth exploration of cannabinoid
Ketamine Cystitis and Sexual Dysfunction in Women: A 2011 Case-Control Study
Introduction In a significant study published in BJU International on December 16, 2011, Jang et al. examined the relationship between
Bladder and Sexual Dysfunction in Women Using Ketamine: Clinical Insights from March 2023
Introduction The March 2023 study by Jong BE et al., published in The Journal of Sexual Medicine, provides new insights
Marijuana Banking: Legal Complexities Hindering the Cannabis Industry” Sourced from McGlinchey Stafford PLLC, 2023
Introduction: McGlinchey Stafford’s 2023 report dives into the challenges faced by the cannabis industry due to conflicting federal and state
Federal vs. State Cannabis Laws: Implications for Healthcare Providers
Key Takeaways: Legal Conflict: Cannabis remains federally illegal but is legal for medical or recreational use in various states, creating
VA Leads Innovation: Psychedelic-Assisted Therapy Study for Veterans with PTSD & AUD (2024)
Introduction In December 2024, the VA launched a groundbreaking study on MDMA-assisted therapy, targeting veterans with PTSD and alcohol use
Cannabis and Schizophrenia: Misconceptions, Mechanisms, and Clinical Considerations (2023, Project CBD)
Introduction The 2023 Project CBD report examines the complex interplay between cannabis use and schizophrenia, challenging common misconceptions and offering